Lonza announced a series of collaborations to exhibit the proprietary Cocoon^® Platform’s ability to manufacture novel cell therapies in a decentralized setting. The collaborations include tech transferring cell therapy manufacturing processes developed independently at the Stanford University School of Medicine, Fred Hutchinson Cancer Research Center, and Parker Institute for Cancer Immunotherapy into the Cocoon platform. Source: Lonza Press Release 9/3/2020